Figure 2 | Scientific Reports

Figure 2

From: Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade

Figure 2

Immune profiles in the tumor microenvironment of fibrolamellar carcinoma and NTL. (A) UMAP displaying myeloid-centered panel flow cytometry analysis of live CD45+ cells from NTL (left) and FLC (right) of patient 14. Each color represents a different immune population. (B) Frequency of CD45+ among live cells in tumor and NTL. (C) Frequency of myeloid populations among CD45+ cells in tumor and NTL. (D) Frequency of innate lymphocyte populations among CD45+ cells in tumor and NTL. (E) Frequency of lymphocyte populations among CD45+ cells in tumor and NTL. (F) Ratio of CD8+ cells to CD4+ and Treg cells in tumor and NTL; All paired T-test, parametric.

Back to article page